1. Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER. Issue 9 (4th June 2014) Authors: Kaplan, S. A.; Cardozo, L.; Herschorn, S.; Grenabo, L.; Carlsson, M.; Arumi, D.; Crook, T. J.; Whelan, L.; Scholfield, D.; Ntanios, F.; the Assessment of Fesoterodine after Tolterodine ER (AFTER) Study Group Journal: International journal of clinical practice Issue: Volume 68:Issue 9(2014) Page Start: 1065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Systematic review of the relationship between bladder and bowel function: implications for patient management. Issue 3 (15th February 2013) Authors: Kaplan, S. A.; Dmochowski, R.; Cash, B. D.; Kopp, Z. S.; Berriman, S. J.; Khullar, V. Journal: International journal of clinical practice Issue: Volume 67:Issue 3(2013) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗